Boothbay Fund Management’s Moderna MRNA Stock Holding History

Boothbay Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$395K	Buy	+7,772	New	+$363K	0.01%	1476
2025 Q4	–	Sell	-13,542	Closed	-$368K	–	2218
2025 Q3	$350K	Buy	13,542 +4,942	+57%	+$138K	0.01%	1361
2025 Q2	$237K	Buy	+8,600	New	+$226K	﹤0.01%	1189
2024 Q3	–	Sell	-3,250	Closed	-$386K	–	1812
2024 Q2	$386K	Buy	+3,250	New	+$411K	0.01%	1077
2024 Q1	–	Sell	-8,140	Closed	-$810K	–	1806
2023 Q4	$810K	Buy	+8,140	New	+$685K	0.02%	801
2023 Q2	–	Sell	-1,713	Closed	-$263K	–	2109
2023 Q1	$263K	Buy	+1,713	New	+$283K	0.01%	1585
2022 Q4	–	Sell	-2,105	Closed	-$344K	–	2284
2022 Q3	$249K	Buy	2,105 +272	+15%	+$41.3K	0.01%	1661
2022 Q2	$262K	Buy	+1,833	New	+$262K	0.01%	1555
2021 Q3	–	Sell	-1,432	Closed	-$336K	–	2086
2021 Q2	$336K	Buy	+1,432	New	+$256K	0.01%	1216
2021 Q1	–	Sell	-8,850	Closed	-$1.28M	–	1691
2020 Q4	$925K	Buy	+8,850	New	+$895K	0.03%	519
2019 Q1	–	Sell	-15,000	Closed	-$229K	–	835
2018 Q4	$229K	Buy	+15,000	New	+$247K	0.03%	459

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's MRNA Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Moderna (MRNA) in Q1 2026: 7,772 shares worth $395K. The stake represents 0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in MRNA as recently as Q3 2025.

Boothbay Fund Management first reported a position in MRNA in Q4 2018 and has held it in 11 quarters since. The position peaked at $925K in Q4 2020. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Boothbay Fund Management held 7,772 shares of Moderna worth $395K as of Q1 2026.
Moderna was a new Boothbay Fund Management position in Q1 2026.
Moderna made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1476 holding.
Boothbay Fund Management first reported a position in Moderna in Q4 2018 and has held it in 11 quarters since.
Boothbay Fund Management's Moderna position peaked at $925K in Q4 2020.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.